Jun 15, 2026 06:53AM
Jun 4, 2026 07:30AM
Jun 2, 2026 07:00AM
Jun 2, 2026 07:00AM
May 12, 2026 04:05PM
May 1, 2026 12:15PM
May 1, 2026 12:15PM Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
Mar 25, 2026 07:02AM
Mar 25, 2026 06:58AM
Mar 25, 2026 06:37AM
Mar 25, 2026 05:33AM
Mar 24, 2026 03:40PM
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
Feb 12, 2026 04:05PM
Jan 8, 2026 04:13AM
Jan 7, 2026 07:00AM
Jan 7, 2026 07:00AM
Dec 12, 2025 06:43AM
Dec 11, 2025 07:00AM
Dec 11, 2025 07:00AM Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
Nov 6, 2025 04:05PM
Sep 18, 2025 05:27AM
Sep 17, 2025 04:05PM
Sep 3, 2025 06:49AM
Sep 2, 2025 07:30AM
Sep 2, 2025 07:30AM
May 28, 2025 02:27PM BTIG Reiterates Buy Rating on Rezolute (rzlt)
May 28, 2025 08:02AM
May 28, 2025 08:00AM
May 13, 2025 04:05PM
May 5, 2025 08:02AM
May 5, 2025 08:00AM
Feb 12, 2025 04:05PM
Feb 5, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Rezolute (RZLT)
Feb 4, 2025 08:00AM
Feb 4, 2025 08:00AM
Jan 7, 2025 08:02AM
Jan 7, 2025 08:00AM
Dec 5, 2024 08:00AM
Dec 4, 2024 06:01AM
Dec 3, 2024 08:00AM Rezolute Inc. (RZLT): FDA Grants Orphan Drug Designation to Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Dec 3, 2024 08:00AM
Sep 27, 2024 06:50AM
Sep 20, 2024 11:55AM
Sep 20, 2024 05:22AM
Sep 19, 2024 04:05PM
Sep 10, 2024 06:43AM
Sep 9, 2024 11:58AM Rezolute (RZLT) PT Raised to $15 at BTIG
Sep 9, 2024 08:38AM

323,147 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All